Mr. Grant Froese reports

HARVEST ONE ANNOUNCES FRANK HOLLER AS NEW CHAIRMAN OF THE BOARD

Harvest One Cannabis Inc. has named Frank Holler as chairman, effective immediately. Mr. Holler first joined the board as a director in September, 2018. Peter Wall, Harvest One's former chairman of the board, will remain on the board as a director.

Grant Froese, Harvest One's chief executive officer, commented: "Frank's experience, particularly in the pharmaceutical industry and capital markets, strengthens the depth of expertise on the Harvest One board. We're delighted he's stepping in as chairman as this further sets us up for a landmark year in 2019."

Mr. Holler, who is president and CEO of Ponderosa Capital Inc., is an expert in biotechnology, investment banking and venture capital. He previously served as CEO and partner of Lions Capital Corp., fund manager for BC Advantage Funds and the Lions Funds; as president and CEO of Xenon Pharmaceuticals Inc., a private genomics-based drug development company; as president and CEO of ID Biomedical Corp., a vaccine development company sold to GlaxoSmithKline PLC; and as a founding director of Angiotech Pharmaceuticals, a Toronto Stock Exchange-/Nasdaq Stock Market-listed medical device company. Before working in biotechnology and health care, Mr. Holler was an investment banker with Merrill Lynch Canada and Wood Gundy Inc. (now CIBC World Markets).

At the board meeting Mr. Froese thanked departing chairman Peter Wall for his service, saying, "On behalf of the board, I would like to thank Peter for his contributions to Harvest One over the past few years and we're pleased he's staying on as a director."

About Harvest One Cannabis Inc.

Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. The company's range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly owned subsidiaries: United Greeneries, a licensed producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer); and a minority interest in Burb Cannabis (retail operations).

We seek Safe Harbor.